Autoimmune Dysautonomia and Gastrointestinal Dysmotility Panel, Serum
Also known as: AIDYS
Use
This test is used to evaluate idiopathic dysautonomia symptoms and gastrointestinal dysmotility symptoms or to differentiate between autoimmune dysautonomia or gastrointestinal dysmotility and the effects of chemotherapy in individuals with these symptoms who are receiving cancer treatment.
Special Instructions
Not provided.
Limitations
This test is developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. Results should be interpreted in correlation with the patient's clinical history and other laboratory findings.
New York Approved
Methodology
Cell-based / Cytometry
Biomarkers
LOINC Codes
- 61177-2 - Paraneoplastic Ab Ser Ql IF
- 82979-6 - CASPR2 IgG SerPl Ql IF
- 82978-8 - LGI1 IgG SerPl Ql IF
- 72504-4 - CV2 Ab SerPl Ql IF
- 42233-7 - nAChR Ab Ser-sCnc
- 94676-4 - DPPX IgG Ser Ql CBA IFA
Result Turnaround Time
3-10 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3 mL
Minimum Volume
1.5 mL
Container
Serum separator tube (SST)
Collection Instructions
Separate from cells ASAP or within 2 hours of collection. Transfer three 1 mL serum aliquots to ARUP standard transport tubes.
Storage Instructions
Frozen
Causes for Rejection
Amniotic fluid, ocular fluid, peritoneal fluid, synovial fluid, CSF, or plasma. Contaminated, hemolyzed, icteric, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 14 days |
| Frozen | 1 month |
Other tests from different labs that may be relevant